MedPath

Surveillance study of the frequency of the primary aldosteronism included in the hypertensive patient for an untreated hypertensive patient at the time of the first medical examination: multi-center survey.

Not Applicable
Conditions
Primary aldosteronism
Registration Number
JPRN-UMIN000009328
Lead Sponsor
Japan Physicians Association
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
5000
Inclusion Criteria

Not provided

Exclusion Criteria

The patient who is taking a hypotensive drug.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath